BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity.EBI
Osaka Prefecture University
Identification of allosteric ERK2 inhibitors through in silico biased screening and competitive binding assay.EBI
Osaka Prefecture University
5Z-7-Oxozeaenol covalently binds to MAP2K7 at Cys218 in an unprecedented manner.EBI
Osaka Prefecture University
Molecular design of small organic molecules based on structural information for a conformationally constrained peptide that binds to G-CSF receptor.EBI
Osaka Prefecture University
Structural basis for the inhibitor recognition of human Lyn kinase domain.EBI
Osaka Prefecture University
Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.EBI
Osaka Prefecture University
Structural basis for producing selective MAP2K7 inhibitors.EBI
Osaka Prefecture University
An isoform-selective inhibitor of tropomyosin receptor kinase A behaves as molecular glue.EBI
Osaka Prefecture University